Clinical features, management and outcomes of severe ischaemic stroke in tertiary hospitals in China: Protocol for a prospective multicentre registry-based observational study

BMJ Open

Volumn 8, Issue 10, 2018, Pages

  Wu, Simiao ^a   Yuan, Ruozhen ^a   Xiong, Yao ^a,b   Zhang, Shihong ^a   Wu, Bo ^a   Liu, Ming ^a  

^a SICHUAN UNIVERSITY   (China)

^b Third Hospital of Chengdu   (China)

Author keywords

ischaemic stroke; malignant; management; prognosis; risk factors; severe

Indexed keywords

ACUTE DISEASE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL FEATURE; CLINICAL PROTOCOL; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GLASGOW COMA SCALE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANKIN SCALE; REGISTER; RISK FACTOR; SAMPLE SIZE; SURVIVAL RATE; TELEPHONE INTERVIEW; TERTIARY CARE CENTER; X-RAY COMPUTED TOMOGRAPHY; EPIDEMIOLOGY; METHODOLOGY; MORTALITY; MULTICENTER STUDY (TOPIC); SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

BRAIN ISCHEMIA; CHINA; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MULTICENTER STUDIES AS TOPIC; OBSERVATIONAL STUDIES AS TOPIC; PROSPECTIVE STUDIES; REGISTRIES; RESEARCH DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TERTIARY CARE CENTERS;

EID: 85055613195     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2018-024900     Document Type: Article

References (22)

1. Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379:2352-63.
2. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82.
3. Torbey MT, Bösel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine. Neurocrit Care 2015;22:146-64.
4. Kasner SE, Demchuk AM, Berrouschot J, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001;32:2117-23.
5. Bill O, Zufferey P, Faouzi M, et al. Severe stroke: patient profile and predictors of favorable outcome. J Thromb Haemost 2013;11:92-9.
6. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16:14-19.
7. Huttner HB, Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol 2009;8:949-58.
8. Whiteley WN, Thompson D, Murray G, et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke 2014;45:1000-6.
9. Thompson DD, Murray GD, Candelise L, et al. Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials. Int J Stroke 2015;10:1024-30.
10. Whiteley WN, Adams HP, Bath PM, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol 2013;12:539-45.
11. Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1222-38.
12. Lorenzano S, Toni D. TESPI trial Investigators. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset. Int J Stroke 2012;7:250-7.
13. Den Hertog HM, van der Worp HB, Tseng MC, et al. Cooling therapy for acute stroke. Cochrane Database Syst Rev 2009:Cd001247.
14. Sandercock PA, Soane T. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2011:Cd000064.
15. Bereczki D, Fekete I, Prado GF, et al. Mannitol for acute stroke. Cochrane Database Syst Rev 2007:Cd001153.
16. Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009;8:326-33.
17. Jüttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007;38:2518-25.
18. Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007;38:2506-17.
19. Hofmeijer J, Algra A, Kappelle LJ, et al. Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc Dis 2008;25:176-84.
20. Wardlaw JM, Sellar R. A simple practical classification of cerebral infarcts on CT and its interobserver reliability. AJNR Am J Neuroradiol 1994;15:1933-9.
21. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
22. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.